CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 123 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,363 | +623.2% | 385,676 | +419.8% | 0.04% | +485.7% |
| Q4 2022 | $465 | -99.8% | 74,194 | +43.1% | 0.01% | +600.0% |
| Q3 2021 | $189,000 | -68.4% | 51,853 | -50.3% | 0.00% | -91.7% |
| Q4 2020 | $599,000 | +1147.9% | 104,393 | +653.0% | 0.01% | +1100.0% |
| Q2 2020 | $48,000 | -58.3% | 13,864 | -38.7% | 0.00% | -80.0% |
| Q3 2019 | $115,000 | -57.9% | 22,633 | -8.4% | 0.01% | -88.4% |
| Q3 2018 | $273,000 | – | 24,709 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,254,502 | $20,741,000 | 14.54% |
| Versant Venture Management, LLC | 1,048,601 | $9,647,127,000 | 10.15% |
| Abingworth LLP | 1,147,077 | $10,553,000 | 7.65% |
| Omega Fund Management, LLC | 551,477 | $5,074,000 | 3.67% |
| Opaleye Management Inc. | 665,000 | $6,118,000 | 1.96% |
| DAFNA Capital Management LLC | 361,164 | $3,323,000 | 1.79% |
| Boxer Capital, LLC | 1,012,986 | $9,319,000 | 1.70% |
| Foresite Capital Management III, LLC | 600,000 | $5,520,000 | 1.55% |
| NEXTHERA CAPITAL LP | 536,568 | $4,936,000 | 0.91% |
| Perceptive Advisors | 2,685,882 | $24,710,000 | 0.82% |